Bladder Cancer Nursing Care Plan & Management
Description
- Bladder cancer is papillomatous growth in the bladder urothelium that undergo malignant changes and that may infiltrate the bladder wall.
- Predisposing factors include cigarette smoking, exposure to industrial chemicals and exposure to radiation.
- Common signs of metastasis include the liver, bones and lungs
- As the tumor progresses can extend to the rectum, vagina and retro- peritoneal structures.
Assessment
- Painless hematuria
- Dysuria
- Gross hematuria
- Obstruction of urine flow
- Development of fistula ( urine from the vagina, fecal material in the urine)
Diagnostic Evaluation
Biopsies of the tumor and adjacent mucosa are definitive, but the following procedures are also used:
- Cystoscopy, biopsy of tumor and adjacent mucosa
- Excretory urography
- Computed CT Scan
- Ultrasonography
- Bimanual examination by anesthesia
- Cytologic evaluation of fresh urine and saline bladder washings
Molecular assays, bladder tumor antigens, adhesion molecules and others are being studied.
Primary Nursing Diagnosis
- Risk for altered urinary elimination related to the obstruction of urinary flow
Medical Management
Radiation
- Most bladder cancer are poorly radio sensitive and require high doses of radiation
- Radiation therapy is more acceptable for advance disease that cannot be eradicated by surgery.
- Palliative radiation maybe used to relieve pain and bowel obstruction and control potential hemorrhage and leg edema cause by venous or lymphatic obstruction.
- Intracavitary radiation maybe prescribed which protect adjacent tissues.
- External radiation combined with chemotherapy or surgery maybe prescribed because the external radiation alone maybe ineffective.
- Complications of radiations:
- A bacterial cystitis
- Proctitis
- Fistula formation
- Ileitis or colitis
- Bladder ulceration and hemorrhage
Chemotherapy
1. Intravesical instillation
- An alkylating chemotherapeutic agent is instilled into the bladder
- This method provides an concentrated topical treatment with little systemic absorption
- Chemotherapeutic agents used may include thiotepa, mitomycin (Mutamycin), doxorubicin (Adriamycin), cyclophosphamide (Cytoxan), and bacille Calmette-Guerin.
- The medication is injected into a urethral catheter and retain for two hours.
- Following instillation, the clients position is rotated every 15 to 30 minutes, starting in the supine position to avoid lying on full bladder.
- After 2 hours, the client voids in a sitting position and is instructed to increase fluids to flash the bladder.
- Treat the urine as biohazard and send to radioisotope laboratory for monitoring.
- For 6 hours following intravesical therapy, disinfect the toilet with household bleach after the client has voided.
2. Systemic chemotherapy
- Systemic chemotherapy is used to treat inoperable or late tumors.
- Agents used may include, cysplatin (Platinol), doxorubicin (Adremycin), cyclophospamide (Cytosan), methotrexate (Folex) and Pyridoxine
3. Complications of chemotherapy
- Bladder irritation
- Hemorrhagic cystitis
Surgical Interventions
1. Transurethral resection of the bladder
- Local resection and fulguration ( destruction of tissue by electrical current through electrodes place in direct contact with the tissue)
- Perform for early tumor for cure or for inoperable tumors for palliation.
2. Partial Cystectomy
- Partial cystectomy is the removal of up to half of the bladder
- The procedure is done for early tumors and for clients who cannot tolerate radical cystectomy.
- During the initial postoperative period bladder capacity is reduced greatly to about 60 mL; however, as the bladder tissue expand, the capacity increases to 200 -400 mL.
- Maintenance of a continuous output of urine following surgery is critical to prevent bladder distention and stress on the suture line.
- A urethral catheter and a suprapubic catheter maybe in place, in the suprapubic catheter maybe left in place for 2 weeks until healing occurs.